Active Biotech AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was SEK 12.5 million compared to SEK 15 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.06 a year ago.

Diluted loss per share from continuing operations was SEK 0.04 compared to SEK 0.06 a year ago.